Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 4636 AL 4650

The Gut-Brain Axis in Alzheimer's Disease and Omega-3. A Critical Overview of Clinical Trials

La Rosa F, Clerici M, Ratto D, Occhinegro A, Licito A, Romeo M, Iorio CD, Rossi P.

Nutrients. 2018 Sep 8;10(9):1267. doi: 10.3390/nu10091267.

Rollercoaster ride of kynurenines: steering the wheel towards neuroprotection in Alzheimer's disease

Sharma R, Razdan K, Bansal Y, Kuhad A.

Expert Opin Ther Targets. 2018 Oct;22(10):849-867. doi: 10.1080/14728222.2018.1524877. Epub 2018 Sep 25.

DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective

Pathak A, Rohilla A, Gupta T, Akhtar MJ, Haider MR, Sharma K, Haider K, Yar MS.

Eur J Med Chem. 2018 Oct 5;158:559-592. doi: 10.1016/j.ejmech.2018.08.093. Epub 2018 Sep 11.

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group.

PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep.

Global View on Alzheimer's Disease and Diabetes Mellitus: Threats, Risks and Treatment Alzheimer's Disease and Diabetes Mellitus

Klimova B, Kuca K, Maresova P.

Curr Alzheimer Res. 2018;15(14):1277-1282. doi: 10.2174/1567205015666180925110222.

Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition

Grizzanti J, Corrigan R, Casadesus G.

J Alzheimers Dis. 2018;66(1):11-23. doi: 10.3233/JAD-180433.

Alzheimer's Disease, time to turn the tide

Sensi SL.

Aging (Albany NY). 2018 Oct 13;10(10):2537-2538. doi: 10.18632/aging.101581.

Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients

Zhang N, Gordon ML.

Clin Interv Aging. 2018 Oct 11;13:1963-1970. doi: 10.2147/CIA.S159920. eCollection 2018.

Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study

Sarycheva T, Lavikainen P, Taipale H, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen AM.

J Am Heart Assoc. 2018 Sep 18;7(18):e009742. doi: 10.1161/JAHA.118.009742.

Advances in developing novel therapeutic strategies for Alzheimer's disease

Cao J, Hou J, Ping J, Cai D.

Mol Neurodegener. 2018 Dec 12;13(1):64. doi: 10.1186/s13024-018-0299-8.

Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis

Kennedy RE, Cutter GR, Fowler ME, Schneider LS.

JAMA Netw Open. 2018 Nov 2;1(7):e184080. doi: 10.1001/jamanetworkopen.2018.4080.

Mindfulness mechanisms and psychological effects for aMCI patients: A comparison with psychoeducation

Larouche E, Hudon C, Goulet S.

Complement Ther Clin Pract. 2019 Feb;34:93-104. doi: 10.1016/j.ctcp.2018.11.008. Epub 2018 Nov 12.

Does Caring for a Spouse With Dementia Accelerate Cognitive Decline? Findings From the Health and Retirement Study

Dassel KB, Carr DC, Vitaliano P.

Gerontologist. 2017 Apr 1;57(2):319-328. doi: 10.1093/geront/gnv148.

Professional carers' experiences of caring for individuals with intellectual disability and dementia

Cleary J, Doody O.

J Intellect Disabil. 2017 Mar;21(1):68-86. doi: 10.1177/1744629516638245.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias